Wednesday, December 11, 2019


Hexo Corp
(TSX: HEXO.TO) Add to Watchlist
-0.02 (-0.69%)
as of Dec 11, 2019

For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs--given out only for therapies  (full story)
BOSS.CN: 0.235 (-0.005), BOSQF: 0.1798 (-0.0002), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), TRUL.CN: 15.710 (-0.790), TCNNF: 11.9000 (-0.5500), TGOD.TO: 0.76 (-0.02)
Many more Americans now support cannabis legalization. A Pew Research Center survey now finds that 67% are in support. That's up from 62% year. Better, the House Judiciary Committee just passed The Marijuana Opportunity Reinvestment and Expungement (MORE) Act with a vote of 24 to 10. While the bill  (full story)
EAT.CN: 0.040 (unch), SPLIF: 0.0310 (-0.0010), APHA: 4.89 (-0.06), APHA.TO: 6.45 (-0.10), TLRY: 18.20 (-0.35), HEXO: 2.19 (unch)
TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:  (full story)
ZENA.TO: 0.20 (+0.01), ACB.TO: 3.22 (-0.10), HRT.TO: 0.12 (unch), TV.TO: 0.20 (+0.01), HEXO.TO: 2.86 (-0.02), WEED.TO: 26.67 (+0.07), BCE.TO: 64.53 (+0.14)
At the moment, "there are dozens of studies taking place to evaluate the medical safety and efficacy of psychedelics, including psilocybin, and the potential benefits of psychedelics as a treatment for cluster headache, anxiety, addiction to alcohol and other drugs, depression, obsessive-compulsive  (full story)
BOSS.CN: 0.235 (-0.005), BOSQF: 0.1798 (-0.0002), FIRE.TO: 0.62 (-0.03), SPRWF: 0.4800 (-0.0131), WEED.TO: 26.67 (+0.07), CGC: 20.25 (+0.16), HEXO: 2.19 (unch)
GATINEAU, Que. — Hexo Corp. says it is in the process of destroying cannabis that was grown without a licence at a facility it acquired in Niagara, Ont., as part of its purchase of Newstrike Brand Ltd.  (full story)
HEXO.TO: 2.86 (-0.02)
Due to various recent regulatory changes, the cannabis industry is slowly evolving out of the black market and morphing into a global economic powerhouse. While cannabis still remains heavily regulated in most regions around the world, a handful of countries have moved to legalize cannabis for eithe  (full story)
CRFTF: 0.0645 (-0.0044), CRFT.CN: 0.085 (-0.010), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), OGI: 2.56 (-0.02), OGI.TO: 3.36 (-0.06), TGODF: 0.5801 (-0.0084)
CBD is quickly becoming a multi-billion-dollar business. In fact, sales of products containing CBD are expected to grow 700% in 2019 year over year, says the Brightfield Group. "The CBD market has been growing rapidly, but we will see unprecedented growth in 2019," Brightfield Managing Director, Bet  (full story)
CBDN.CN: 0.440 (+0.045), CURA.CN: 7.890 (-0.020), CURLF: 5.9800 (-0.0387), CVSI: 1.1200 (+0.0700), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), FIRE.TO: 0.62 (-0.03)
Anxiety disorders are one of the most common mental illnesses in the U.S., affecting nearly 40 million adults, according to the Anxiety and Depression Association of America. Anxiety disorders are highly treatable, yet only 36.9% of those suffering actually receive treatment. Generally, people with  (full story)
SCQBD: 0.7420 (+0.0079), SDEC: 0.0900 (-0.0500), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), OGI: 2.56 (-0.02), OGI.TO: 3.36 (-0.06), EMHTF: 0.2176 (-0.0074)
The hemp industry made headlines recently, as the U.S. Department of Agriculture (USDA) proposed new draft rules. Currently, under federal regulations, only hemp plants with 0.3% THC or lower are allowed to be commercialized. However, under the new rules, cannabis plants with up to 0.5% THC would be  (full story)
CRFTF: 0.0645 (-0.0044), CRFT.CN: 0.085 (-0.010), CGC: 20.25 (+0.16), WEED.TO: 26.67 (+0.07), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), CURLF: 5.9800 (-0.0387)
Since passage of the U.S. Farm Bill in 2018, the CBD market is moving towards mainstream retailers with sales projected to be well over $20 billion by 2024, according to a report from BDS Analytics and Arcview Market Research, as noted by Forbes. "Because of the tremendous range of products in which  (full story)
BOSS.CN: 0.235 (-0.005), BOSQF: 0.1798 (-0.0002), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), CURA.CN: 7.890 (-0.020), CURLF: 5.9800 (-0.0387), CL.CN: 7.860 (+0.450)
The long-term cannabis growth story is still intact. Canada legalized cannabis use in 2018, and just legalized derivatives as part of Cannabis 2.0. More U.S. states are approving it. Many more Americans are now in favor of legalization, too. A Gallup survey found that 66% of Americans are in favor  (full story)
BOSS.CN: 0.235 (-0.005), BOSQF: 0.1798 (-0.0002), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), CTST: 0.82 (-0.01), ZBISF: 0.1469 (+0.0019)
GATINEAU, Que. — Hexo Corp. says it lost $56.7 million in its latest quarter compared with a loss of $10.5 million in the same quarter a year ago.  (full story)
HEXO.TO: 2.86 (-0.02)
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.